Evidence map›Paper›PMID 26391136›Full record

SynthesisJournal of the American Heart Association2015

Impact of Contact Force Technology on Atrial Fibrillation Ablation: A Meta-Analysis.

Mohammed Shurrab, Luigi Di Biase, David F Briceno, Anna Kaoutskaia, Saleem Haj-Yahia, David Newman, Ilan Lashevsky, Hiroshi Nakagawa, Eugene Crystal

Registry-linked trialAbstract readMeta-AnalysisReview
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Journal of the American Heart Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04078685 (Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias), which is not on this map. Cited by 44 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04078685 naunknown statusnot on this mapstarted 2018, after this paper: background citation

Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias: a Randomized Controlled Trial

TypeinterventionalSponsorErasmus Medical CenterRan2018 to 2021Enrolled113ConditionsTachycardia, Paroxysmal, Supraventricular, Tachycardia, SupraventricularArmsStandard catheter ablation, Contact Force-sensing-based catheter ablation
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Contact force facilitates the achievement of an unexcitable ablation line during pulmonary vein isolation.Clinical research in cardiology : official journal of the German Cardiac Society · 2018
    Trial
  10. Article
  11. Article
  12. Review
  13. Article
  14. Same-Day Discharge: It's Not Always Better to Sleep Over.Journal of the American Heart Association · 2025
    Article
  15. Global Research Progress on Radiofrequency Ablation in Cardiology.Annals of medicine and surgery (2012) · 2025
    Review
  16. Article
  17. Association between body mass index and results of cryoballoon ablation in Korean patients with atrial fibrillation: an analysis from the Korean Heart Rhythm Society Cryoablation registry.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohammed ShurrabArrhythmia Services, Cardiology Department, An-Najah National University Hospital, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine (M.S., S.H.Y.) Arrhythmia Services, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada (M.S., A.K., D.N., I.L., E.C.).
Luigi Di BiaseMontefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY (L.D.B., D.F.B.) Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, TX (L.D.B.) Department of Biomedical Engineering, University of Texas, Austin, TX (L.D.B.) Department of Cardiology, University of Foggia, Italy (L.D.B.).
David F BricenoMontefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY (L.D.B., D.F.B.).
Anna KaoutskaiaArrhythmia Services, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada (M.S., A.K., D.N., I.L., E.C.).
Saleem Haj-YahiaArrhythmia Services, Cardiology Department, An-Najah National University Hospital, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine (M.S., S.H.Y.) Institute of Cardiovascular and Medical Sciences, The University of Glasgow, Scotland, UK (S.H.Y.).
David NewmanArrhythmia Services, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada (M.S., A.K., D.N., I.L., E.C.).
Ilan LashevskyArrhythmia Services, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada (M.S., A.K., D.N., I.L., E.C.).
Hiroshi NakagawaHeart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK (H.N.).
Eugene CrystalArrhythmia Services, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada (M.S., A.K., D.N., I.L., E.C.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCatheter-tissue contact is essential for effective lesion formation, thus there is growing usage of contact force (CF) technology in atrial fibrillation ablation. We conducted a meta-analysis to assess the impact of CF on clinical outcomes and procedural parameters in comparison to conventional catheter for atrial fibrillation ablation. METHODS AND

resultsAn electronic search was performed using major databases. Outcomes of interest were recurrence rate, major complications, total procedure, and fluoroscopic times. Continuous variables were reported as standardized mean difference; odds ratios were reported for dichotomous variables. Eleven studies (2 randomized controlled studies and 9 cohorts) involving 1428 adult patients were identified. CF was deployed in 552 patients. The range of CF used was between 2 to 60 gram-force. The follow-up period ranged between 10 and 53 weeks. In comparing CF and conventional catheter groups, the recurrence rate was lower with CF (35.1% versus 45.5%, odds ratio 0.62 [95% CI 0.45-0.86], P=0.004). Shorter procedure and fluoroscopic times were achieved with CF (procedure time: 156 versus 173 minutes, standardized mean difference -0.85 [95% CI -1.48 to -0.21], P=0.009; fluoroscopic time: 28 versus 36 minutes, standardized mean difference -0.94 [95% CI -1.66; -0.21], P=0.01). Major complication rate was lower numerically in the CF group but not statistically significant (1.3% versus 1.9%, odds ratio 0.71 [95% CI 0.29-1.73], P=0.45).

conclusionsThe use of CF technology results in significant reduction of the atrial fibrillation recurrence rate after atrial fibrillation ablation in comparison to the conventional catheter group. CF technology is able to significantly reduce procedure and fluoroscopic times without compromising complication rate.

Indexed as

Atrial FibrillationCardiac CathetersCatheter AblationChi-Square DistributionEquipment DesignHumansOdds RatioOperative TimeRadiation DosageRadiography, InterventionalRecurrenceRisk FactorsTime FactorsTreatment Outcomeablationatrial fibrillationcontact forcemeta‐analysis

Identifiers

PMID26391136
PMCPMC4599513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.